SUMMARY
Legionella longbeachae is one of the least known of the pathogenic legionella species. The organism was first isolated in 1980 from respiratory tract secretions of four patients with pneumonia. It was named after the geographical location (Longbeach, California, U.S.A.) where the first patient was hospitalized and where the clinical laboratory which isolated the strain was located 1 . Legionella longbeachae infection is reported from many countries including Sweden 2 , Germany 3 and Australia 4, 5 . Legionella longbeachae is a fastidious organism and difficult to culture in vitro. Epidemiological studies have shown that the bacteria is widely distributed in the soil and potting mixes available in Australia 5 . The diagnosis relies primarily on detecting a fourfold rise in antibody titre to the legionella antigen, and if possible, culturing the organism from the sputum or on immunofluorescence microscopy studies of sputum.
Two cases were referred to the Intensive Care Unit with a diagnosis of respiratory failure secondary to atypical pneumonia. In the first case serological and histological diagnosis was made of Legionella longbeachae. In the second case serological evidence of Legionella longbeachae was detected but lung biopsy and sputum examination were negative. We then investigated the role of serological examination in the diagnosis of Legionella longbeachae infections in the Intensive Care Unit.
METHODS
Following an index case of Legionella longbeachae, all patients admitted to the Intensive Care Unit over a two-month period with the clinical syndrome of ARDS were screened for serological evidence of legionella infection. The serological testing for legionella species was performed on admission and subsequently every 7 to 10 days from that date. The serum was tested for presence of antibodies to Legionella pneumophilia type 1, Legionella pneumophilia type 2 and Legionella longbeachae type 1. The tests were performed interstate at a major reference laboratory with an interest in legionella infections and in the natural distribution of the organism 6 . All patients admitted to the critical care unit have prospective data collected including basic demographic data, diagnosis, APACHE II scoring 7 , and outcome. Patients were classified as suffering from ARDS on the basis of the chest X-ray showing pulmonary oedema, hypoxaemia unresponsive to oxygen therapy and exclusion of elevated pulmonary capillary pressure.
RESULTS
Fifty-nine patients were admitted to the Intensive Care Unit in the two-month study period. The clinical diagnosis of the patients ventilated for eight days or more in the two-month period is shown in Table 1 . Table 2 gives the patient outcome and Legionella longbeachae serology results. Patients numbered 1 through 6 had initial blood samples and follow-up blood samples tested. Patients 7, 8 and 9 had no initial sample due to failure to collect the sample (2) or due to late transfer to our hospital 1 . These patients had diagnostically high titres to Legionella longbeachae. Patients 10, 11 and 12 were ventilated for over eight days but did not meet the criteria for a diagnosis of ARDS. None of these patients (10, 11 and 12) had an antibody rise to Legionella longbeachae. Patient 7 had an elevated titre to Legionella pneumophilia type 1, with an IgM antibody; no other patient developed a Legionella pneumophilia antibody. Serology testing for Mycoplasma pneumoniae antibodies (five patients), influenza virus A and B (two patients) were negative.
Samples of water from the ventilator humidification system, swabs of the ventilator tubing and ventilator circuits were cultured for the presence of legionella species with negative results.
Patient 2 is described in detail.
Patient 2
A 71-year-old woodturner and non-smoker presented with a three-day history of fever, dry cough and shortness of breath. He was admitted because of increasing confusion, lethargy and chest tightness. On examination he looked unwell, was febrile with a central temperature of 39°C, blood pressure 80/40 mmHg, with signs of right middle and lower lobe consolidation and bilateral basal inspiratory crackles. He had an oxygen saturation of 85% on 100% oxygen by rebreathing mask. He was intubated and ventilated. Penicillin, cefotaxime and erythromycin were commenced. Fluid loading and inotropic support were started to treat the hypotension. Initial improvement was followed one week later by increasing oxygen requirements and recurrent fever. Open lung biopsy showed diffuse alveolar damage. Histochemical stains for legionella were negative. Immunofluorescent staining of multiple sputum samples was negative for legionella species. A fourfold rise in antibody titre to Legionella longbeachae was demonstrated on immunofluorescent assay and rifampicin was therefore added to his therapy. The patient developed cholestatic hepatitis. Ciprofloxacin was substituted. The illness was complicated by invasive Candida albicans. The patient died due to multi-organ failure after 26 days in ICU.
DISCUSSION
In community-acquired pneumonia a fourfold rise in the titre of Legionella longbeachae is indicative of infection with the organism 8 . In the patients suffering ARDS a fourfold elevation in titre was not associated with diagnostic evidence of infection. Efforts to identify the organism from the sputum by culture or immunofluorescent staining in all patients with a rising titre were unsuccessful. Lung biopsy was not successful in demonstrating the organism in two patients. This evidence suggests that the elevation in titre is not associated with a primary Legionella longbeachae infection.
It is possible that failure to isolate the organism represents a laboratory failure to isolate the organism. The original case of Legionella longbeachae was diagnosed by both antibody titre elevation and isolation of the organism, thus the laboratory was able to perform the test on that occasion. Assuming that detection methods for the organism were accurate, then these cases of elevation of the antibody titre represent an epiphenomenon.
The severe illnesses suffered by the patients may have caused a polyclonal increase in the production of gamma globulin, a cross-reacting antibody to Legionella longbeachae being among the increased antibodies produced. This would cause an elevation of the Legionella longbeachae antibody titre but not in response to the specific stimulation of the antibody production by the organism. Against the antibody elevation being an epiphenomenon is the observation that there was no increase in the antibody titre to Legionella pneumophilia types 1 and 2, or to Mycoplasma pneumoniae and influenza virus. It remains possible that the immune response produces a Legionella longbeachae antibody and that the titre elevation is an epiphenomenon. The polymicrobial infections in critical patients or the stimulation of the immune system by the leakage of gut organisms into the portal circulation may be the stimulus to production of a cross-reacting antibody.
The elevation in titre may represent an infection acquired in the intensive care unit, a nosocomial infection. In this event the failure to isolate the organism may relate to the early use of antibiotic with some activity against Legionella longbeachae. Legionella species have been associated with nosocomial infection in patients with normal and suppressed immune systems. Infection has been ascribed to using tap water to wash patients' surgical wounds 9 . Careful microbiological examination of the intensive care unit, including screening of the ventilators, samples of the water used for humidification and the ventilator circuits did not detect legionella species and in particular Legionella longbeachae. Thus the acquisition of legionella infection in the intensive care unit seems unlikely but cannot be fully excluded. Patients treated with mechanical ventilation but without ARDS did not have a rise in titre. These patients were exposed to the same environment but did not develop antibodies to Legionella longbeachae, suggesting but not proving that there was no source of infection in the intensive care unit environment.
Legionella longbeachae is a ubiquitous organism that may cause subclinical infections in humans. The severe illness suffered by our patients may have stimulated a reactivation of the organism, in the manner that immunosuppression may lead to a recrudescence of cytomegalovirus infection or Pneumocystis carinii infection. The organism was unable to be cultured due to antibiotic activity and the production of antibody directed against Legionella longbeachae. Although possible it is unlikely that all patients had had exposure or that all patients would be able to reactivate the infection.
As the possibility of the legionella infection could not be fully excluded, all patients were treated with antibiotics active against Legionella longbeachae, usually erythromycin or ciprofloxacin. Most patients recovered after antibiotic therapy directed against Legionella longbeachae, but the role of the antibiotic therapy is unclear and the recovery does not help resolve the question.
This study raises questions about the accuracy of a fourfold elevation of antibody titre to Legionella longbeachae in diagnosing Legionella longbeachae infection in critically ill patients with a diagnosis of ARDS. Titre elevation in this group of patients may represent infection but alternatively could be an epiphenomenon of little significance. We favour the viewpoint that the titre rise represents an epiphenomenon.
